Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (621-630 of 633) with videos related to

Pageof 64
Sort By:
Cancer Research|September 30, 2010
Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transportersYan-Jun Mi, Yong-Ju Liang, Hong-Bing Huang, et al.
Cancer Research|October 3, 2008
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2Chun-ling Dai, Amit K Tiwari, Chung-Pu Wu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|July 12, 2005
[Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances]Zhi-Hua Zhu, Tie-Hua Rong, Can-Guang Zeng, et al.
Medcomm|March 12, 2024
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancerShiwen Huo, Jinqi Xue, Shuo Wang, et al.
Signal Transduction and Targeted Therapy|September 6, 2022
Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1Fan Liang, Gui-Zhen Wang, Yan Wang, et al.
Molecular Cancer|February 8, 2022
Targeting HNRNPU to overcome cisplatin resistance in bladder cancerZhen-Duo Shi, Lin Hao, Xiao-Xiao Han, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 20, 2016
1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 InhibitorsYi-Chao Zheng, Long-Zhen Wang, Li-Jie Zhao, et al.
Ebiomedicine|March 2, 2020
Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesisXin-Chun Zhao, Gui-Zhen Wang, Zhe-Sheng Wen, et al.
Journal of Hematology & Oncology|May 30, 2015
Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftmentsWei Ye, Zhiwu Jiang, Guan-Xiong Li, et al.
Cell Research|January 1, 2025
Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone lossWenyu Fu, Meng Chen, Kaidi Wang, et al.
Pageof 64

Showing results (621-630 of 633) with videos related to

Sort By:
Pageof 64
Cancer Research|September 30, 2010
Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transportersYan-Jun Mi, Yong-Ju Liang, Hong-Bing Huang, et al.
Cancer Research|October 3, 2008
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2Chun-ling Dai, Amit K Tiwari, Chung-Pu Wu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|July 12, 2005
[Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances]Zhi-Hua Zhu, Tie-Hua Rong, Can-Guang Zeng, et al.
Medcomm|March 12, 2024
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancerShiwen Huo, Jinqi Xue, Shuo Wang, et al.
Signal Transduction and Targeted Therapy|September 6, 2022
Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1Fan Liang, Gui-Zhen Wang, Yan Wang, et al.
Molecular Cancer|February 8, 2022
Targeting HNRNPU to overcome cisplatin resistance in bladder cancerZhen-Duo Shi, Lin Hao, Xiao-Xiao Han, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 20, 2016
1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 InhibitorsYi-Chao Zheng, Long-Zhen Wang, Li-Jie Zhao, et al.
Ebiomedicine|March 2, 2020
Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesisXin-Chun Zhao, Gui-Zhen Wang, Zhe-Sheng Wen, et al.
Journal of Hematology & Oncology|May 30, 2015
Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftmentsWei Ye, Zhiwu Jiang, Guan-Xiong Li, et al.
Cell Research|January 1, 2025
Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone lossWenyu Fu, Meng Chen, Kaidi Wang, et al.
Pageof 64